Biological markers for identifying patients for treatment with vegf antagonists
作者： Matthew Brauer , Carlos Bais , Maike Schmidt , Mallika Singh
DOI:
关键词: Antagonist 、 Bioinformatics 、 VEGF receptors 、 Pharmacology 、 Medicine
摘要: Methods and compositions to detect expression of one or more biomarkers for identifying treating patients who are likely be responsive VEGF antagonist therapy disclosed. Also disclosed kits articles manufacture use in the methods.
lens.org 参考文章(89)
Richard A Olshen, Charles J Stone, Leo Breiman, Jerome H Friedman, Classification and regression trees ,(1983)
David Lane, Ed Harlow, Antibodies: A Laboratory Manual ,(1988)
Corey Speers, Novel Strategies for the Treatment of Estrogen Receptor-Negative Breast Cancer Defense Technical Information Center. ,(2007) , 10.21236/ADA478493
Herbert A. Lieberman, Martin M. Rieger, Gilbert S. Banker, Pharmaceutical Dosage Forms: Disperse Systems ,(1988)
Jessy Deshane, David T. Curiel, Methods for modulating protein function in cells using intracellular antibody homologues ,(1995)
Patrick Aebischer, Shelley R. Winn, Pierre M. Galletti, In vivo delivery of neurotransmitters by implanted, encapsulated cells ,(1988)
Carlos F. Barbas, Christoph Rader, Humanization of murine antibody ,(1998)
Giannoula Klement, Judah Folkman, Platelet biomarkers for the detection of disease ,(2005)
Stephen P. A. Fodor, Michael C. Pirrung, Lubert Stryer, J. Leighton Read, Array of oligonucleotides on a solid substrate ,(1992)
Joseph A. Tami, Michael D. Parr, Stephen A. Brown, John S. Thompson, Monoclonal antibody technology American Journal of Health-system Pharmacy. ,vol. 43, pp. 2816- 2825 ,(1986) , 10.1093/AJHP/43.11.2816